Matches in SemOpenAlex for { <https://semopenalex.org/work/W966191659> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W966191659 endingPage "3482" @default.
- W966191659 startingPage "3482" @default.
- W966191659 abstract "Purpose: The aim of this work was to characterize the clinical correctness of FFF prostate treatment VMAT plans based on analysis of DVHs reconstructed from pre-verification 2D-arrays measurements. Methods: The new 2D ion chamber array 1500 with rotational phantom cylindrical Octavius 4D and Verisoft 6.1 software with DVH option (PTW, Freiburg) were used to determine the clinical usefulness of the treatment plans. Ten patients treated with VMAT high-fractionated (2 fraction × 7,5 Gy) FFF prostate plans (TrueBeam, Varian) were analyzed using the 3D gamma analysis by local dose method with a 5% threshold for various tolerance parameters DTA [mm] and DD [%] were 1%/1, 2%/2, 3%/3. Additional, based on the measurements of irradiation dose distributions and patients’ CT scans with contoured structures of organs, the DVHs were reconstructed using a software. The obtained DVHs were compared to planned dose distributions and the deviations were analysed with parameters: for CTV D50, D98, D2, and D25, D50, Dmax for OARs — rectum, bladder and left/right femoral heads. Results: The analyzed treatment plans passed gamma criteria (3/3%; 95%), the results obtained were as follow: mean value and standard deviation of gamma score for criteria (DTA[mm]/DD[%]): 1/1% (L53.3±3.2); 2/2% (L87.0±2.2); 3/3% (L97.5±0.9). In the DVH analysis, the highest differences were observed for OARs (especially for bladder): the mean percentage differences values for rectum, bladder and left/right femoral heads were: D25 (1.67; 6.83)%, D50 (0.18; 7.18; 1.53; 0.30)%, Dmax (−0.84; −1.64; 0.37; −4.63)%, respectively. For the CTV mean relative deviations for proper parameters were in good agreement with TPS: D98 (0.95±2.21)%, D50 (1.93±0.67)%, D2 (1.76±0.76)%. Conclusion: The gamma method is recommended tool for pre-verification analysis of correctness of treatment plans. Moreover, the scrutiny checking with reconstructed DVH gives additional, clinical information about quality of plan, especially about coverage of CTV and sparing of health tissues." @default.
- W966191659 created "2016-06-24" @default.
- W966191659 creator A5046597261 @default.
- W966191659 creator A5072367835 @default.
- W966191659 date "2015-06-01" @default.
- W966191659 modified "2023-10-18" @default.
- W966191659 title "SU-E-T-634: Pre-Verification of FFF Prostate VMAT Plans with Gamma Method and DVHs Reconstructed Based On Measurements with 2D-ARRAY (PTW 1500) and OCTAVIUS 4D" @default.
- W966191659 doi "https://doi.org/10.1118/1.4924997" @default.
- W966191659 hasPublicationYear "2015" @default.
- W966191659 type Work @default.
- W966191659 sameAs 966191659 @default.
- W966191659 citedByCount "1" @default.
- W966191659 countsByYear W9661916592020 @default.
- W966191659 crossrefType "journal-article" @default.
- W966191659 hasAuthorship W966191659A5046597261 @default.
- W966191659 hasAuthorship W966191659A5072367835 @default.
- W966191659 hasConcept C104293457 @default.
- W966191659 hasConcept C120665830 @default.
- W966191659 hasConcept C121332964 @default.
- W966191659 hasConcept C168834538 @default.
- W966191659 hasConcept C180048950 @default.
- W966191659 hasConcept C2780271382 @default.
- W966191659 hasConcept C2989005 @default.
- W966191659 hasConcept C33923547 @default.
- W966191659 hasConcept C71924100 @default.
- W966191659 hasConceptScore W966191659C104293457 @default.
- W966191659 hasConceptScore W966191659C120665830 @default.
- W966191659 hasConceptScore W966191659C121332964 @default.
- W966191659 hasConceptScore W966191659C168834538 @default.
- W966191659 hasConceptScore W966191659C180048950 @default.
- W966191659 hasConceptScore W966191659C2780271382 @default.
- W966191659 hasConceptScore W966191659C2989005 @default.
- W966191659 hasConceptScore W966191659C33923547 @default.
- W966191659 hasConceptScore W966191659C71924100 @default.
- W966191659 hasIssue "6Part22" @default.
- W966191659 hasLocation W9661916591 @default.
- W966191659 hasOpenAccess W966191659 @default.
- W966191659 hasPrimaryLocation W9661916591 @default.
- W966191659 hasRelatedWork W2051111147 @default.
- W966191659 hasRelatedWork W2072660622 @default.
- W966191659 hasRelatedWork W2081418639 @default.
- W966191659 hasRelatedWork W2460236564 @default.
- W966191659 hasRelatedWork W2470045800 @default.
- W966191659 hasRelatedWork W2582601468 @default.
- W966191659 hasRelatedWork W2888535554 @default.
- W966191659 hasRelatedWork W2895910545 @default.
- W966191659 hasRelatedWork W2936479790 @default.
- W966191659 hasRelatedWork W2955316531 @default.
- W966191659 hasVolume "42" @default.
- W966191659 isParatext "false" @default.
- W966191659 isRetracted "false" @default.
- W966191659 magId "966191659" @default.
- W966191659 workType "article" @default.